Obstacles in assessing adherence to oral antipsychotic medications
Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), A.L. Miller, Desiree Castillo, Larry Ereshefsky(The University of Texas at San Antonio Health Science Center), Margaret DiCocco(The University of Texas at San Antonio Health Science Center), Y. W. Francis Lam, N.L. Maples
Cited by 3
Related Papers
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325